MeSH Browser

MeSH Supplementary: capecitabine-irinotecan combination
Unique ID: C520768
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/C520768
Entry Term(s): CAPIRI; bXELIRI
Registry Numbers: 0
Heading Mapped to: *Antineoplastic Combined Chemotherapy Protocols; Camptothecin / analogs & derivatives; Deoxycytidine / analogs & derivatives; Fluorouracil / analogs & derivatives
Frequency: 23
Note: a phase II study of biweekly dose-intensified oral capecitabine plus irinotecan (bXELIRI) for patients with advanced or metastatic gastric cancer 5/2007
Source: Br J Cancer 2007 May 21;96(10):1514-9
Date of Entry: 2007/06/28
Revision Date: 2013/11/06

capecitabine-irinotecan combination MeSH Supplementary Concept Data 2025